ESGO supports The European Organisation for Treatment of Trophoblastic Diseases(EOTTD) which has become a special task force under the ESGO umbrella focused on topics related to trophoblastic diseases.
The European Organisation for Treatment of Trophoblastic Diseases is dedicated to optimize diagnosis, treatment, follow-up and research in Gestational Trophoblastic Disease (GTD) by bringing together knowledge of clinicians and researchers working in the field of GTD in Europe.
The task force’s primary objective is to bring together all European players in the field of GTD. In order to optimize diagnosis, treatment, follow-up and research in GTD four working parties have been established on:
These working parties set their own goals and report on their proceedings on every annual EOTTD meeting.
Watch 15 webscasts from the latest EOTTD annual meeting on ESGO eAcademy.
Subscribe today to eAcademy and gain free access to view
Future perspectives in gestational trophoblastic disease
François Golfier, Lyon, France
Michael Seckl, London, UK - firstname.lastname@example.org Leon Massuger, Nijmegen, The Netherlands - email@example.com Nienke van Trommel, Nijmegen, The Netherlands, Secretary - firstname.lastname@example.org
Support open-access webinars from ESGO and help us create more educational opportunties.
Get notified on all news and activities right in your mailbox.